Jaguar Gene Therapy, LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases including those that impact sizeable patient populations. The company is made up of a proven team of experts with unparalleled CMC (Chemistry, Manufacturing and Controls), regulatory, clinical and commercial acumen who have first-hand experience in bringing novel gene therapy treatments to patients and their families. Committed to patient safety and product purity, Jaguar is rapidly advancing an initial pipeline of three programs targeting: 1) Type 1 galactosemia; 2) a genetic cause of autism spectrum disorder and Phelan-McDermid syndrome and other severe neurodevelopmental disorders with a SHANK3 mutation or deletion; and 3) Type 1 diabetes. The company continues to evaluate opportunities to expand its pipeline using the strength of the team and close relationships with numerous academic institutions.
Company Details
- Employees
- 40
- Founded
- -
- Address
- Lake Forest, Il, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.jaguargenetherapy.com
- HQ
- Lake Forest, IL
Jaguar Gene Therapy Questions
Jaguar Gene Therapy's website is http://www.jaguargenetherapy.com
Jaguar Gene Therapy's LinkedIn profile is https://www.linkedin.com/company/jaguargenetherapy
Jaguar Gene Therapy has
40 employees.
View email and phone details for 40
employees at Jaguar Gene Therapy.
Jaguar Gene Therapy's industry is
Biotechnology Research
Jaguar Gene Therapy's top competitors are
Taysha Gene Therapies,
Kriya Therapeutics, Inc.,
Encoded Therapeutics Inc.,
Beam Therapeutics,
Sarepta Therapeutics,
Apertura Gene Therapy,
Precision Biosciences, Inc.,
Medtherapy Biotech,
Axovia Therapeutics,
Askbio Inc..
Jaguar Gene Therapy's categories are Biotechnology Research
Jaguar Gene Therapy's founding year is 2019
